Donna Lorenson - 23 Aug 2023 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role
Chief Corp. Affairs Officer
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Issuer symbol
KVUE
Transactions as of
23 Aug 2023
Net transactions value
$0
Form type
4
Filing time
25 Aug 2023, 18:03:11 UTC
Previous filing
08 May 2023
Next filing
04 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVUE Restricted Stock Units Award $0 +3,252 $0.000000 3,252 23 Aug 2023 Common Stock 3,252 Direct F1, F2
transaction KVUE Restricted Stock Units Award $0 +2,815 $0.000000 2,815 23 Aug 2023 Common Stock 2,815 Direct F1, F3
transaction KVUE Restricted Stock Units Award $0 +2,511 $0.000000 2,511 23 Aug 2023 Common Stock 2,511 Direct F1, F4
transaction KVUE Restricted Stock Units Award $0 +8,371 $0.000000 8,371 23 Aug 2023 Common Stock 8,371 Direct F5, F6
transaction KVUE Restricted Stock Units Award $0 +7,038 $0.000000 7,038 23 Aug 2023 Common Stock 7,038 Direct F3, F5
transaction KVUE Restricted Stock Units Award $0 +8,023 $0.000000 8,023 23 Aug 2023 Common Stock 8,023 Direct F4, F5
transaction KVUE Stock Options Award $0 +26,906 $0.000000 26,906 23 Aug 2023 Common Stock 26,906 $21.97 Direct F2, F7
transaction KVUE Stock Options Award $0 +27,795 $0.000000 27,795 23 Aug 2023 Common Stock 27,795 $22.40 Direct F3, F7
transaction KVUE Stock Options Award $0 +27,610 $0.000000 27,610 23 Aug 2023 Common Stock 27,610 $22.23 Direct F4, F7
transaction KVUE Stock Options Award $0 +37,596 $0.000000 37,596 23 Aug 2023 Common Stock 37,596 $20.44 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.
F2 This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date.
F3 This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date.
F4 This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date.
F5 These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years.
F6 This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date.
F7 These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value.
F8 This award is fully vested